[1] |
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. DOI: 10.3322/caac.21660.
doi: 10.3322/caac.21660
|
[2] |
Cao W, Chen HD, Yu YW, et al. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020[J]. Chin Med J (Engl), 2021, 134(7): 783-791. DOI: 10.1097/CM9.0000000000001474.
doi: 10.1097/CM9.0000000000001474
|
[3] |
GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019[J]. Lancet, 2020, 396(10258): 1223-1249. DOI: 10.1016/S0140-6736(20)30752-2.
doi: 10.1016/S0140-6736(20)30752-2
pmid: 33069327
|
[4] |
GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2018, 392(10159): 1789-1858. DOI: 10.1016/S0140-6736(18)32279-7.
doi: S0140-6736(18)32279-7
pmid: 30496104
|
[5] |
Armstrong RA. When to use the Bonferroni correction[J]. Ophthalmic Physiol Opt, 2014, 34(5): 502-508. DOI: 10.1111/opo.12131.
doi: 10.1111/opo.12131
|
[6] |
Rosenberg PS, Check DP, Anderson WF. A web tool for age-period-cohort analysis of cancer incidence and mortality rates[J]. Cancer Epidemiol Biomarkers Prev, 2014, 23(11): 2296-2302. DOI: 10.1158/1055-9965.EPI-14-0300.
doi: 10.1158/1055-9965.EPI-14-0300
|
[7] |
杨秀丽. DNA损伤修复基因XPG、XPC、WRN单核苷酸多态性与乳腺癌易感性的研究[D]. 沈阳: 中国医科大学, 2010. DOI: 10.7666/d.y2052036.
doi: 10.7666/d.y2052036
|
[8] |
郑文龙, 张辉, 张爽, 等. 天津市1999-2017年女性乳腺癌死亡水平变化趋势分析[J]. 中华流行病学杂志, 2020, 41(9): 1477-1481. DOI: 10.3760/cma.j.cn112338-20191018-00741.
doi: 10.3760/cma.j.cn112338-20191018-00741
|
[9] |
Tu WJ, Zeng XW, Liu Q. Aging tsunami coming: the main finding from China's seventh national population census[J]. Aging Clin Exp Res, 2022, 34(5): 1159-1163. DOI: 10.1007/s40520-021-02017-4.
doi: 10.1007/s40520-021-02017-4
|
[10] |
Sun L, Sadique Z, Dos-Santos-Silva I, et al. Cost-effectiveness of breast cancer screening programme for women in rural China[J]. Int J Cancer, 2019, 144(10): 2596-2604. DOI: 10.1002/ijc.31956.
doi: 10.1002/ijc.31956
pmid: 30367451
|
[11] |
Zou XN. Epidemic trend, screening, and early detection and treatment of cancer in Chinese population[J]. Cancer Biol Med, 2017, 14(1): 50-59. DOI: 10.20892/j.issn.2095-3941.2016.0047.
doi: 10.20892/j.issn.2095-3941.2016.0047
|
[12] |
王永斌, 马石头, 王焕, 等. 我国妇女生育水平变化及未来人口预测[J]. 中国卫生统计, 2017, 34(1): 34-36, 39.
|
[13] |
周淼, 周晓明, 周业庭. 乳腺癌与人乳头瘤病毒感染关系研究进展[J]. 中华实验外科杂志, 2009, 26(6): 813-814. DOI: 10.3760/cma.j.issn.1001-9030.2009.06.059.
doi: 10.3760/cma.j.issn.1001-9030.2009.06.059
|
[14] |
Kobayashi S, Sugiura H, Ando Y, et al. Reproductive history and breast cancer risk[J]. Breast Cancer, 2012, 19(4): 302-308. DOI: 10.1007/s12282-012-0384-8.
doi: 10.1007/s12282-012-0384-8
pmid: 22711317
|
[15] |
Heer E, Harper A, Escandor N, et al. Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study[J]. Lancet Glob Health, 2020, 8(8): e1027-e1037. DOI: 10.1016/S2214-109X(20)30215-1.
doi: 10.1016/S2214-109X(20)30215-1
pmid: 32710860
|
[16] |
仇雨临, 王昭茜, 冉晓醒. 中国共产党领导下的中国医保: 发展道路与经验总结[J]. 东岳论丛, 2021, 42(10): 5-11. DOI: 10.15981/j.cnki.dongyueluncong.2021.10.002.
doi: 10.15981/j.cnki.dongyueluncong.2021.10.002
|